109 related articles for article (PubMed ID: 22379856)
1. [Metastasizing of follicular thyroid cancer to the skull base].
Zh Vopr Neirokhir Im N N Burdenko; 2011; 75(4):75-81. PubMed ID: 22379856
[TBL] [Abstract][Full Text] [Related]
2. Skull base metastasis from follicular thyroid carcinoma -two case reports-.
Matsuno A; Katakami H; Okazaki R; Yamada S; Sasaki M; Nakaguchi H; Yamada SM; Hoya K; Murakami M; Yamazaki K; Ishida Y; Iwasaki H; Kuyama J; Kakudo K
Neurol Med Chir (Tokyo); 2010; 50(5):421-5. PubMed ID: 20505304
[TBL] [Abstract][Full Text] [Related]
3. [Skull base metastasis from differentiated thyroid carcinoma: 3 cases report and review of literature].
Chen Z; Qiu QH; Zhang QH; Zhu ZC; Peng Y; Liu H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):881-884. PubMed ID: 29775008
[TBL] [Abstract][Full Text] [Related]
4. Sella turcica metastasis from follicular carcinoma of thyroid.
Yilmazlar S; Kocaeli H; Cordan T
Neurol Res; 2004 Jan; 26(1):74-8. PubMed ID: 14977061
[TBL] [Abstract][Full Text] [Related]
5. Management considerations for differentiated thyroid carcinoma presenting as a metastasis to the skull base.
Mydlarz WK; Wu J; Aygun N; Olivi A; Carey JP; Westra WH; Tufano RP
Laryngoscope; 2007 Jul; 117(7):1146-52. PubMed ID: 17489069
[TBL] [Abstract][Full Text] [Related]
6. [Clinical picture of differentiated thyroid carcinoma in the T1 stage].
Czarniecka A; Włoch J; Lange D
Wiad Lek; 2001; 54 Suppl 1():225-33. PubMed ID: 12182030
[TBL] [Abstract][Full Text] [Related]
7. Follicular thyroid carcinoma with skull metastases.
Chiofalo MG; Setola SV; Di Gennaro F; Fulciniti F; Catapano G; Losito NS; Sandomenico F; Catalano O; Pezzullo L
Endocr J; 2015; 62(4):363-9. PubMed ID: 25797278
[TBL] [Abstract][Full Text] [Related]
8. [Current state of the treatment of thyroid cancer].
Paches AI; Liubaev VL; Shental' VV; Pustynskiĭ IN; Abdullin NA
Vopr Onkol; 1998; 44(5):562-6. PubMed ID: 9884715
[TBL] [Abstract][Full Text] [Related]
9. Pure follicular thyroid carcinoma: impact of therapy in 214 patients.
Young RL; Mazzaferri EL; Rahe AJ; Dorfman SG
J Nucl Med; 1980 Aug; 21(8):733-7. PubMed ID: 7400828
[TBL] [Abstract][Full Text] [Related]
10. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
11. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
12. [Significance of lymph node metastases in differentiated thyroid carcinoma].
Lerch H; Saur HB; Schober O
Nuklearmedizin; 1995 Oct; 34(5):203-6. PubMed ID: 7479095
[TBL] [Abstract][Full Text] [Related]
13. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
14. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
15. Infratemporal metastasis from occult follicular thyroid carcinoma.
Coca Pelaz A; Llorente JL; Suárez C
J Craniofac Surg; 2009 Jan; 20(1):165-7. PubMed ID: 19165017
[TBL] [Abstract][Full Text] [Related]
16. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
[TBL] [Abstract][Full Text] [Related]
17. Solitary follicular thyroid carcinoma of the skull base and its differentiation from ectopic adenoma--review, use of galectin-3 and report of a new case.
Rosahl SK; Erpenbeck V; Vorkapic P; Samii M
Clin Neurol Neurosurg; 2000 Sep; 102(3):149-55. PubMed ID: 10996713
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.
Durante C; Haddy N; Baudin E; Leboulleux S; Hartl D; Travagli JP; Caillou B; Ricard M; Lumbroso JD; De Vathaire F; Schlumberger M
J Clin Endocrinol Metab; 2006 Aug; 91(8):2892-9. PubMed ID: 16684830
[TBL] [Abstract][Full Text] [Related]
19. Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy.
Beierwaltes WH; Nishiyama RH; Thompson NW; Copp JE; Kubo A
J Nucl Med; 1982 Jul; 23(7):561-8. PubMed ID: 7086528
[TBL] [Abstract][Full Text] [Related]
20. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
